These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 2880302

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Electrophysiological effects of dopamine autoreceptor antagonists, (+)-AJ 76 and (+)-UH 232.
    Piercey MF, Lum JT.
    Eur J Pharmacol; 1990 Jul 03; 182(2):219-26. PubMed ID: 2397740
    [Abstract] [Full Text] [Related]

  • 3. (+)-UH 232 and (+)-UH 242: novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors.
    Svensson K, Hjorth S, Clark D, Carlsson A, Wikström H, Andersson B, Sanchez D, Johansson AM, Arvidsson LE, Hacksell U.
    J Neural Transm; 1986 Jul 03; 65(1):1-27. PubMed ID: 3083041
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vivo dopamine (DA) receptor binding and behavioural effects of the putative DA autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 in rats with a unilateral nigral 6-OH-DA lesion.
    Hajos M, Hjorth S, Svensson K, Carlsson A.
    Exp Brain Res; 1988 Jul 03; 70(3):577-84. PubMed ID: 3133239
    [Abstract] [Full Text] [Related]

  • 6. A homologous series of N-alkylated cis-(+)-(1 S, 2 R)-5-methoxy-1-methyl-2-aminotetralins: central dopamine receptor antagonists showing profiles ranging from classical antagonism to selectivity for autoreceptors.
    Svensson K, Carlsson A, Johansson AM, Arvidsson LE, Nilsson JL.
    J Neural Transm; 1986 Jul 03; 65(1):29-38. PubMed ID: 3958706
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Novel dopamine receptor agonists and antagonists with preferential action on autoreceptors.
    Johansson AM, Arvidsson LE, Hacksell U, Nilsson JL, Svensson K, Hjorth S, Clark D, Carlsson A, Sanchez D, Andersson B.
    J Med Chem; 1985 Aug 03; 28(8):1049-53. PubMed ID: 3927002
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological profiles of the putative dopamine autoreceptor agonists 3-PPP and TL-99.
    Martin GE, Haubrich DR, Williams M.
    Eur J Pharmacol; 1981 Nov 19; 76(1):15-23. PubMed ID: 7318920
    [Abstract] [Full Text] [Related]

  • 11. Effects of the putative dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 on the discriminative stimulus properties of cocaine.
    Callahan PM, Piercey MF, Cunningham KA.
    Psychopharmacology (Berl); 1992 Nov 19; 107(1):73-7. PubMed ID: 1589564
    [Abstract] [Full Text] [Related]

  • 12. Blockade of apomorphine-induced yawning in rats by the dopamine autoreceptor antagonist (+)-AJ 76.
    Dourish CT, Herbert EN, Iversen SD.
    Neuropharmacology; 1989 Dec 19; 28(12):1423-5. PubMed ID: 2615920
    [Abstract] [Full Text] [Related]

  • 13. Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonists.
    Johansson AM, Arvidsson LE, Hacksell U, Nilsson JL, Svensson K, Carlsson A.
    J Med Chem; 1987 Apr 19; 30(4):602-11. PubMed ID: 3560156
    [Abstract] [Full Text] [Related]

  • 14. C1-Methylated 5-hydroxy-2-(dipropylamino)tetralins: central dopamine-receptor stimulating activity.
    Hacksell U, Johansson AM, Arvidsson L, Nilsson JL, Hjorth S, Carlsson A, Wikström H, Sanchez D, Lindberg P.
    J Med Chem; 1984 Aug 19; 27(8):1003-7. PubMed ID: 6431102
    [Abstract] [Full Text] [Related]

  • 15. Central dopaminergic properties of HW-165 and its enantiomers; trans-octahydrobenzo(f)quinoline congeners of 3-PPP.
    Hjorth S, Svensson K, Carlsson A, Wikström H, Andersson B.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jul 19; 333(3):205-18. PubMed ID: 3762735
    [Abstract] [Full Text] [Related]

  • 16. A pharmacological analysis of the effects of (+)-AJ 76 and (+)-UH 232 at release regulating pre- and postsynaptic dopamine receptors.
    Gifford AN, Johnson KM.
    Eur J Pharmacol; 1993 Jun 24; 237(2-3):169-75. PubMed ID: 8103459
    [Abstract] [Full Text] [Related]

  • 17. Interaction of the component enantiomers of the putative dopamine autoreceptor agonist, TL-99 (6,7-dihydroxy-2-dimethylamino tetralin) with dopaminergic systems in mammalian brain and teleost retina.
    Williams M, Martin GE, McClure DE, Baldwin JJ, Watling KJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec 24; 324(4):275-80. PubMed ID: 6141532
    [Abstract] [Full Text] [Related]

  • 18. Yawning induced by the selective dopamine D2 agonist N-0437 is blocked by the selective dopamine autoreceptor antagonist (+)-UH 232.
    Cooper SJ, Rusk IN, Barber DJ.
    Physiol Behav; 1989 Jun 24; 45(6):1263-6. PubMed ID: 2573095
    [Abstract] [Full Text] [Related]

  • 19. Further in vitro and in vivo studies with the putative presynaptic dopamine agonist N,N-dipropyl-7-hydroxy-2-aminotetralin.
    Mulder TB, de Vries JB, Dijkstra D, Wiechers JW, Grol CJ, Horn AS.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov 24; 336(5):494-501. PubMed ID: 2830544
    [Abstract] [Full Text] [Related]

  • 20. N-methyl,N-propargyl-2-aminotetralins:novel dopamine agonists with monoamine oxidase inhibiting properties.
    Hazelhoff B, De Vries JB, Dijkstra D, Mulder TB, Horn AS.
    Eur J Pharmacol; 1985 Feb 26; 109(2):229-40. PubMed ID: 3922776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.